AbbVie Inc. Profile Avatar - Palmy Investing

AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…
Drug Manufacturers - General
US, North Chicago [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

A quick analysis that compared AbbVie Inc. (ABBV) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.

Company Price Change Volume, Avg. Market Cap. Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding
Drug Manufacturers—General Average - - - - - - 52,546.59 5,673.25 784.38 4,046.86 126.36 0.01 -6.6776 0.62 0.5586 0.0059 0.00 0.07 2.4063 - -
Maximum - - - - - - 197,802.00 13,765.00 2,179.00 18,021.00 1,294.00 0.04 46.2856 2.71 0.7672 0.2203 0.03 0.53 21.1421 - -
Minimum - - - - - - 0.00 77.00 -82.00 -1,283.00 -2,626.00 0.00 -311.9276 -0.15 0.0683 -0.9021 -0.08 -0.04 0.0000 - -
AbbVie Inc. ABBV 171.69 3.93 2.34% 2,882 vs. 5,440 303,391.00 12,310.00 1,369.00 3,847.00 -2,384.00 0.7700 58.3938 0.0087 0.6684 0.1112 0.1710 0.0092 0.7229 1,767.00
Gilead Sciences, Inc. GILD 89.77 1.14 1.29% 1,459 vs. 6,733 111,878.00 6,686.00 -4,170.00 2,114.00 10,656.00 -3.3400 -5.4485 0.0109 0.7679 -0.6237 -0.2378 -0.0741 0.8243 1,246.00
Bristol-Myers Squibb Company BMY 58.20 0.32 0.55% 2,928 vs. 11,052 118,040.00 11,865.00 -11,911.00 2,550.00 15,640.00 -5.8900 -2.2500 0.0113 0.7529 -1.0039 -0.7223 -0.1203 0.9190 2,028.00
Pfizer Inc. PFE 25.16 0.23 0.90% 18,588 vs. 36,462 142,609.00 14,879.00 3,115.00 387.00 121,318.00 0.5500 12.5852 0.0151 0.7056 0.2094 0.0338 0.0141 0.5659 5,666.00
Amgen Inc. AMGN 289.54 1.67 0.58% 1,187 vs. 2,169 155,634.00 7,396.00 -113.00 459.00 -27,870.00 -0.2100 -335.6404 0.0080 0.5673 -0.0153 -0.0225 -0.0012 0.8362 537.00
Eli Lilly and Company LLY 748.10 -5.31 -0.70% 2,023 vs. 3,396 710,183.00 8,768.00 2,242.00 179.00 12,553.00 2.4900 76.3636 0.0017 0.8250 0.2558 0.1751 0.0351 0.6775 949.00
Merck & Co., Inc. MRK 99.22 1.78 1.82% 5,657 vs. 9,695 250,978.00 15,809.00 4,762.00 2,229.00 56,697.00 1.8800 17.4190 0.0059 0.7511 0.3012 0.1180 0.0450 0.7284 2,529.00
Johnson & Johnson JNJ 155.38 2.27 1.48% 3,227 vs. 6,343 374,083.00 21,382.00 3,255.00 2,850.00 153,378.00 1.3500 29.1832 0.0076 0.6878 0.1522 0.0465 0.0189 0.8448 2,407.00
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for ABBV and its peers to uncover potential buy and sell opportunities.
End of ABBV's Analysis
CIK: 1551152 CUSIP: 00287Y109 ISIN: US00287Y1091 LEI: - UEI: -
Secondary Listings